Audit Report

Mallinckrodt Pharmaceuticals JA – 531

Audit #: JA - 531
Region: Greenville
Material: API/Excipients
Company: Mallinckrodt Pharmaceuticals
Location: DaOnne Pustelnik 100 Louis Latzer Drive Greenville, IL 62246
Date: 14 May 2015

This Rx-360 Audit Report contains the following scope:

The scope of the audit included the manufacture, packaging, and testing of Acetaminophen, Ibuprofen and Compap. The audit was based on Rx-360 Consortium guidelines for active pharmaceutical ingredients (APIs).